Multidimensional Dyspnea Scale in Interstitial Lung Diseases

  • Research type

    Research Study

  • Full title

    Multidimensional Dyspnoea Scale (MDDS) in Interstitial Lung Diseases: Understanding dyspnoea severity and Impact of MDDS use in Individuals with Interstitial Lung Disease

  • IRAS ID

    321211

  • Contact name

    Shaney Barratt

  • Contact email

    shaney.barratt@nbt.nhs.uk

  • Sponsor organisation

    North Bristol NHS Trust

  • Duration of Study in the UK

    1 years, 0 months, 0 days

  • Research summary

    Breathlessness is a common problem for many patients with interstitial lung disease (ILD). ILD is a group of lung diseases that cause inflammation (swelling) and scarring in the lung tissue where gas exchange (oxygen and carbon dioxide) occurs. Unfortunately there is no cure for these conditions and as a result many patients decline over time with worsening breathlessness. This places serious limits on their ability to live a good life. This is mostly because clinicians do not often recognize, assess or treat breathlessness appropriately. Breathlessness, being a subjective experience, cannot be fully understood through objective measurements such as lung function tests, the arterial blood gas test etc. The objective and subjective measures of breathlessness are frequently disconnected. Clinicians who often rely on these types of tests do not directly enquire, into its nature and severity of breathlessness from patients themselves. As a result, they remain unaware of this disabling symptoms and the extent of its impact on patients. While there are many tools to measure breathlessness, none can assess subjective aspects of breathlessness like severity in a way that can help clinicians identify the problem and prescribe appropriate treatments. This results in needless suffering for patients and their families and prevents them from receiving timely and appropriate therapies. We, therefore, propose to and test an easy to use tool that combines the subjective and objective aspects of breathlessness. We hope that the tool will help clinicians quickly identify the patient’s breathlessness severity and provide them with an algorithm of what to do next. The first step is to examine the tool's psychometric properties, reliability, and validity for use in ILD.

  • REC name

    West of Scotland REC 5

  • REC reference

    23/WS/0058

  • Date of REC Opinion

    11 Apr 2023

  • REC opinion

    Further Information Favourable Opinion